Discover how innovative physical therapy, smart medications, nutrition strategies and mind-body techniques are transforming ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a preclinical-stage pharmaceutical company focused on developing therapies for neurological and neuropsychiatric disorders, today announced the approval and ...

The following is a summary of “A Review of Nonsurgical Neurolytic Procedures for Neuropathic Pain,” published in the February ...

For the nearly 20% of adults battling chronic pain daily, each morning brings the same question: Will today hurt less than ...

A multidisciplinary team of University of Cincinnati Cancer Center researchers is leading a new clinical trial aimed to optimize pain management and reduce the need for opioids after mastectomy ...

A scientific statement regarding pain and treatment considerations in patients with PAD has been published by the AHA.

A multidisciplinary team of University of Cincinnati Cancer Center researchers is leading a new clinical trial aimed to ...

Background: Neuropathic pain is one of the key features of (classical) Fabry disease (FD). No randomized clinical trials comparing effectiveness of different pain management strategies have been ...

A 45-year-old man diagnosed with trigeminal neuralgia, a condition causing severe facial nerve pain, received successful treatment at a Del.

Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...

Having struggled with severe pain for a long time, the opening of a new centralised location for pain treatment at the ...